stars 1 stars 2 stars 3

CellSpring develops blood-based tests for diagnosing early stage cancer. The tests rely on a proprietary exosomal biomarker discovery technology developed at world class research institutes in Switzerland. Detecting cancer early means catching it before a patient even has symptoms -- when the full gamut of therapeutic options is available and most likely to succeed.

CellSpring Questions

The CellSpring annual revenue was $6 million in 2026.

CellSpring is based in Zürich ETH-Hönggerberg, Zurich.

The NAICS codes for CellSpring are [541713, 5417, 541, 54171, 54].

The SIC codes for CellSpring are [873, 87].

Learn More
How It Works
get free account
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups.
search page
Search the #1 Contact Database
Get contact details of over 700M profiles across 60M companies – all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension.
get contact page
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users